Half-Life and Clinical Implications of Dobutamine

Pharmacokinetics and Safety

• The brief half-life of dobutamine provides a safety advantage, as adverse effects resolve quickly after stopping or reducing the infusion, according to the European Society of Cardiology and American Heart Association guidelines 1, 2

Clinical Considerations

• Dose titration is necessary due to wide inter-patient variability in response to dobutamine, with the short half-life allowing rapid adjustment, as recommended by the American College of Cardiology 2